COVID-19 vaccine study awarded to Colorado Springs company
As the battle against COVID-19 continues around the world, one Colorado Springs company is taking a major step toward finding a vaccine.
COLORADO SPRINGS, Colo. (KKTV) - As the battle against COVID-19 continues around the world, one Colorado Springs company is taking a major step toward finding a vaccine.
On Wednesday, the Lynn Health Science Institute of Colorado Springs announced it was awarded the Moderna Phase III COVID-19 Vaccine Study. The study is taking place this month and will last about two years. The study is focused on healthy people who are 18 and older. Dr. Ripley Hollister, a board-certified internal medicine physician, will be the principal investigator for the study.
“The study will determine if participants receiving the potential vaccine develop antibodies that contribute to virus resistance for COVID-19,” a release from the Lynn Health Science Institute of Colorado Springs read. “Interested participants must meet the inclusion and exclusion criteria that has been established by Moderna, Inc. clinical trial protocol. If successful, the data from this trial could lead to the development of the first vaccine for COVID-19.”
Participants who have been diagnosed with active COVID-19 or recovered from a COVID-19 infection are not eligible to participate in the study.
Click here for more information on taking part in the study.
Copyright 2020 KKTV. All rights reserved.